Grandi, A.; Tomasi, M.; Ullah, I.; Bertelli, C.; Vanzo, T.; Accordini, S.; Gagliardi, A.; Zanella, I.; Benedet, M.; Corbellari, R.;
et al. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine. Vaccines 2023, 11, 1546.
https://doi.org/10.3390/vaccines11101546
AMA Style
Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R,
et al. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine. Vaccines. 2023; 11(10):1546.
https://doi.org/10.3390/vaccines11101546
Chicago/Turabian Style
Grandi, Alberto, Michele Tomasi, Irfan Ullah, Cinzia Bertelli, Teresa Vanzo, Silvia Accordini, Assunta Gagliardi, Ilaria Zanella, Mattia Benedet, Riccardo Corbellari,
and et al. 2023. "Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine" Vaccines 11, no. 10: 1546.
https://doi.org/10.3390/vaccines11101546
APA Style
Grandi, A., Tomasi, M., Ullah, I., Bertelli, C., Vanzo, T., Accordini, S., Gagliardi, A., Zanella, I., Benedet, M., Corbellari, R., Di Lascio, G., Tamburini, S., Caproni, E., Croia, L., Ravà , M., Fumagalli, V., Di Lucia, P., Marotta, D., Sala, E.,
... Grandi, G.
(2023). Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine. Vaccines, 11(10), 1546.
https://doi.org/10.3390/vaccines11101546
